Trials / Conditions / Implantable Cardioverter-Defibrillators

Implantable Cardioverter-Defibrillators

9 registered clinical trials studyying Implantable Cardioverter-Defibrillators.

Status	Trial	Sponsor	Phase
Terminated	Ertugliflozin to Reduce Arrhythmic Burden in ICD/CRT patientS (ERASe-Trial) - a Phase III Study NCT04600921	Medical University of Graz	Phase 3
Completed	Defibrillation Testing During Implantable Cardioverter Defibrillator (ICD) Replacement NCT04206371	CMC Ambroise Paré	N/A
Unknown	Increasing Detection of Sub-Clinical Atrial Fibrillation in Defibrillator Patients With the Use of a VDD-ICD L NCT03110627	Unity Health Toronto	N/A
Completed	Study Evaluating the Use of MRI on CMS Patients NCT02513056	University of Pennsylvania	—
Completed	LONGEVITY Study. Evaluation of the Device and Battery Longevity of Boston Scientific Market-released ICD and C NCT02091011	Boston Scientific Corporation	—
Unknown	Internet-based Intervention in Cardioverter-defibrillator Patients to Enhance Quality of Life NCT00895700	Tilburg University	N/A
Completed	Enhancing Knowledge Implantable Cardioverter-Defibrillators (ICDs) NCT00822965	M.D. Anderson Cancer Center	—
Completed	Deactivation of Implantable Cardioverter Defibrillator During Non-thoracic Surgical Procedures NCT00806377	Minneapolis Heart Institute Foundation	—
Completed	Benefits of Implantable Cardioverter Defibrillator Follow-up Using Remote Monitoring NCT00989417	Biotronik SE & Co. KG	N/A